High Dose Nimodipine Treatment Adjunct - 1

National Institutes of Health (NIH)

Status and phase: Completed; Phase 2

Conditions: Cocaine-Related Disorders

Treatments: Drug: Nimodipine

Study type: Interventional

Funder types: Other U.S. Federal agency; NIH

Identifiers

NCT00000332

Y01-3-0009-1

NIDA-3-0009-1

Details and patient eligibility

About

The purpose of this study is to determine if nimodipine is more effective than placebo in reducing stimulated craving for cocaine in cocaine dependent individuals denied access to cocaine in inpatient unit.

Sex: All

Ages: 22 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.